Lecture 3 - Foundations of Venture Capital:
The MedTech Venture Sector
Overview
Lecture 3 introduces a repeatable way to read any investment sector, using MedTech as the worked example. The one idea: a large market and an impressive technology do not, by themselves, make an investment thesis. To evaluate a sector you have to understand what it includes, who holds power within it, what forces shape adoption, where private capital is flowing, and how value is ultimately realized at exit.
Applied to healthcare, the lens reveals a field that is really four segments in one — biopharma, health tech, medical devices, and diagnostics/tools — each with its own risk profile, timeline, and set of buyers. The session frames the current market as a dynamic, "risk-on" up-cycle, and closes on a specific structural observation: fewer investors compete at the earliest stage, which is exactly where disciplined entry can produce the highest return on invested capital.
Learning Objectives
By the end of this session, a participant should be able to:
-
Apply a five-question framework to read any sector.
-
Break healthcare venture into its major segments and understand how they differ.
-
Identify the market forces and participants that shape adoption and pricing.
-
Explain where capital concentrates and where the early-stage gap sits.
-
Understand how MedTech value is realized through strategic acquisition and public markets.
Key Concepts Covered
-
The five-question sector lens: sector, participants, forces, private markets, public/exit markets
-
The four healthcare venture segments and their distinct dynamics
-
Reading a market cycle and the state of the IPO and M&A windows
-
Strategic acquirers as the primary exit path in devices
-
The early-stage gap and disciplined entry valuation
Guest Speaker
This session featured a fireside conversation with Jonathan Norris of HSBC Innovation Banking, author of the healthcare venture research that supplied the market data discussed.
Go Deeper
-
HSBC Innovation Banking — Venture Healthcare Report, Mid-Year 2026 (Jonathan Norris)
Educational content only. Not investment, legal, or tax advice, and not an offer of any security.